- Home
- ICLR vs ALLE Comparison
ICLR vs ALLE Comparison
Compare ICLR & ALLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICLR | ALLE |
|---|---|---|
| Founded | 1990 | 2013 |
| Country | Ireland | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 13.1B |
| IPO Year | 2001 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ICLR | ALLE |
|---|---|---|
| Price | $203.11 | $192.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 11 |
| Target Price | ★ $231.29 | $193.64 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 10-27-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 1.16% |
| EPS Growth | N/A | ★ 9.09 |
| EPS | N/A | ★ 6.33 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.11 |
| Revenue Next Year | $4.60 | $5.97 |
| P/E Ratio | ★ $12.91 | $29.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $66.57 | $125.00 |
| 52 Week High | $219.04 | $192.48 |
Technical Indicators
Market Signals| Indicator | ICLR | ALLE |
|---|---|---|
| Relative Strength Index (RSI) | 65.97 | 78.88 |
| Support Level | $157.92 | $151.79 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 9.22 | 4.02 |
| MACD | 3.10 | 2.84 |
| Stochastic Oscillator | 70.69 | 91.86 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.